- Home
- WDC vs TMO Comparison
WDC vs TMO Comparison
Compare WDC & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDC | TMO |
|---|---|---|
| Founded | 1970 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4B | 164.3B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WDC | TMO |
|---|---|---|
| Price | $484.24 | $446.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 18 |
| Target Price | $281.77 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 6.2M | 2.4M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | 0.12% | ★ 0.40% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | ★ 16.05 | 4.43 |
| Revenue | $9,520,000,000.00 | ★ $20,918,000,000.00 |
| Revenue This Year | $32.24 | $6.55 |
| Revenue Next Year | $26.55 | $5.11 |
| P/E Ratio | ★ $30.17 | $101.29 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $50.62 | $385.46 |
| 52 Week High | $525.15 | $643.99 |
Technical Indicators
Market Signals| Indicator | WDC | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 63.57 | 39.33 |
| Support Level | $246.63 | N/A |
| Resistance Level | $525.15 | $502.20 |
| Average True Range (ATR) | 27.01 | 13.14 |
| MACD | -4.83 | 0.05 |
| Stochastic Oscillator | 55.32 | 27.15 |
Price Performance
Historical ComparisonAbout WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).